| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.23B | 1.15B | 2.84B | 1.64B | 3.51B | 3.52B |
| Gross Profit | 12.52M | 13.99M | 92.37M | -344.72M | 74.10M | 40.93M |
| EBITDA | -124.54M | -626.25M | -1.73B | -1.39B | -632.84M | -370.04M |
| Net Income | -1.24B | -1.26B | -2.68B | -2.83B | -1.78B | -1.57B |
Balance Sheet | ||||||
| Total Assets | 4.72B | 4.83B | 5.64B | 11.11B | 15.74B | 16.99B |
| Cash, Cash Equivalents and Short-Term Investments | 49.47M | 36.81M | 66.15M | 68.39M | 164.94M | 229.62M |
| Total Debt | 5.21B | 5.02B | 5.08B | 6.82B | 11.11B | 11.12B |
| Total Liabilities | 12.69B | 12.42B | 11.95B | 14.77B | 16.58B | 15.88B |
| Stockholders Equity | -8.09B | -7.62B | -6.35B | -3.70B | -850.62M | 1.10B |
Cash Flow | ||||||
| Free Cash Flow | -12.32M | 90.48M | 686.56M | -53.24M | 14.40M | -641.08M |
| Operating Cash Flow | -9.97M | 93.57M | 689.21M | -42.48M | 453.89M | -329.37M |
| Investing Cash Flow | 7.89M | -2.19M | 1.19B | 92.14M | -357.34M | 258.15M |
| Financing Cash Flow | -6.21M | -119.89M | -1.87B | -115.99M | -158.42M | 22.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$151.20M | 5.98 | 3.61% | ― | -12.19% | 108.93% | |
56 Neutral | HK$114.45M | 344.44 | 0.07% | ― | 5.65% | ― | |
48 Neutral | HK$86.16M | -0.06 | ― | ― | -15.10% | 31.07% | |
45 Neutral | HK$142.00M | -2.29 | -15.93% | ― | -25.21% | 12.04% | |
43 Neutral | €136.14M | -9.90 | -2.05% | ― | -13.57% | 34.43% | |
39 Underperform | HK$71.39M | ― | ― | ― | -41.93% | 76.10% |
China Huajun Group Limited has announced a further extension of the long stop date related to the subscription of new shares under a general mandate. The completion of the subscription agreement is contingent upon the fulfillment of certain conditions, which has necessitated extending the deadline from October 31, 2025, to December 31, 2025. This extension allows additional time to meet the conditions, while all other terms of the agreement remain unchanged.
The most recent analyst rating on (HK:0377) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.
China Huajun Group Limited is actively addressing a disclaimer of opinion from its auditor regarding its financial statements and going concern status. The company is implementing an action plan that includes an offshore debt restructuring and issuing new shares to improve its financial standing. The restructuring became effective in June 2025, and the company plans to issue 24,600,000 new shares to creditors by the end of the year. Additionally, a subscription agreement was made to issue 12,000,000 new shares, with proceeds aimed at general working capital and debt repayment. The company is committed to resolving the disclaimer of opinion and will continue to update stakeholders on its progress.
The most recent analyst rating on (HK:0377) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.
China Huajun Group Limited has released a supplemental announcement regarding its 2024 Annual Report, focusing on its Share Option Scheme. The company has detailed the number of shares available for issuance under the scheme, which represents approximately 9.80% of the total shares in issue as of the report date. This announcement provides clarity on the company’s share management and may impact investor perceptions regarding the company’s financial strategies.
The most recent analyst rating on (HK:0377) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.
China Huajun Group Limited has announced an extension of the Long Stop Date for the subscription of new shares under a general mandate. The company, which operates in various sectors, is seeking additional time to fulfill the conditions precedent of the Subscription Agreement. The Long Stop Date has been extended from 31 August 2025 to 31 October 2025, allowing more time for the completion of the agreement. This extension indicates the company’s ongoing efforts to meet its strategic objectives and could impact its operational timelines and stakeholder expectations.
The most recent analyst rating on (HK:0377) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.
China Huajun Group Limited has announced its unaudited interim results for the six months ending June 30, 2025. The results, which comply with the listing requirements of the Hong Kong Stock Exchange, are available on the company’s website and will be dispatched to shareholders preferring printed copies in early September. The announcement reflects the company’s commitment to transparency and provides stakeholders with insights into its financial performance during the first half of the year.
The most recent analyst rating on (HK:0377) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.
China Huajun Group Limited has announced a board meeting scheduled for August 29, 2025, to approve the interim results for the first half of the year and to consider an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.